A theoretical study of the response of vascular tumours to different types of chemotherapy

Mathematical and Computer Modelling

Volumn 47, Issue 5-6, 2008, Pages 560-579

  Panovska, Jasmina ^a   Byrne, Helen M ^b   Maini, Philip K ^c  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Single and combined therapy; Vascular tumour

Indexed keywords

CELLS; CHEMOTHERAPY; COMPUTER SIMULATION; DRUG INFUSION; MATHEMATICAL MODELS; PARTIAL DIFFERENTIAL EQUATIONS;

ANGIOGENIC STIMULANTS; ANTI PROLIFERATIVE DRUG; NONLINEAR PARTIAL DIFFERENTIAL EQUATIONS; SINGLE AND COMBINED THERAPY; TUMOUR VASCULATURE; VASCULAR TUMORS;

TUMORS;

EID: 38849187846     PISSN: 08957177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcm.2007.02.028     Document Type: Article

References (55)

1. Casciari J.J., Sotirchos S.V., and Sutherland R.M. Variations in tumour growth rates and metabolism with oxygen concentration, glucose concentration and extracellular pH. J. Cell. Physiol. 151 (1992) 386-394
2. Sutherland R.M. Cell and environment interactions in tumour microregions: The multicell spheroid model. Science 240 (1988) 177-184
3. Muthukkaruppan V.R., Kubai L., and Auerbach R. Tumour-induced neovascularisation in the mouse eye. J. Natl. Cancer Inst. 69 (1982) 699-705
4. Baptist-Trimbos J., and Trimmers P. Chemotherapy for early ovarian cancer. Curr. Opin. Obstet. XC Gyn. 16 1 (2004) 43-48
5. www.cancer.org/docroot/ETO/content/ETO12XSurgery.asp
6. http://www.breastcancer.org/treatment/radiation/index.jsp
7. http://www.hopkinsmedicine.org/radiosurgery/disorders/braintumors.cfm
8. www.pbs.org/wgbh/nova/cancer/treatments.htm
9. Cheng J.C., Chuang V.P., Cheng S.H., Huang A.T., Lin Y., Cheng T., Yang P., You D., Jian J.J., Tsai S.Y., Sung J., and Horng S. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int. J. Rad. Oncol. Biol. Phys. 47 2 (2000) 435-442
10. www.tirgan.com/chemolist.htm
11. http://home.attbi.com/apparat/articles/cancer.html
12. Stoll B.R., Migliorini C., Kadambi A., Munn L.L., and Jain R.K. A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumours: Implications for anti-angiogenic therapy. Blood 102 (2003) 2555-2561
13. Rowinsky E.K., and Donehower R.C. Paclitaxel (Taxol). N. Engl. J. Med. 223 (1995) 1004-1014
14. http://www.cancerguide.org/rcc_thalidomide.html
15. http://www.oxigene.com/vascular/combretastatin.asp?sf=t
16. Sherratt J.A., and Chaplain M.A.J. A new mathematical model for avascular tumour growth. J. Math. Biol. 43 (2001) 291-312
17. Ward J.P., and King J.R. Mathematical modelling of avascular-tumour growth II: Modelling growth saturation. IMA J. Math. Appl. Med. Biol. 16 (1999) 171-211
18. Gatenby R.A., and Gawlinski E.T. A reaction-diffusion model of cancer invasion. Cancer Res. 56 (1996) 5745-5753
19. Sherratt J.A., and Nowak M.A. Oncogenes, anti-oncogenes and the immune response to cancer: A mathematical model. Proc. R. Soc. Lond. 248 (1992) 261-271
20. Anderson A.R.A., and Chaplain M.A.J. Continuous and discrete mathematical models of tumour-induced angiogenesis. Bull. Math. Biol. 60 (1998) 857-900
21. Byrne H.M., and Chaplain M.A.J. Mathematical models for tumour angiogenesis-numerical simulations and non-linear wave solutions. Bull. Math. Biol. 57 (1995) 461-486
22. Orme M.E., and Chaplain M.A.J. A mathematical model of the first steps of tumour-related angiogenesis: Capillary sprout formation and secondary branching. IMA. J. Math. Appl. Med. Biol. 13 (1996) 73-98
23. Orme M.E., and Chaplain M.A.J. Two-dimensional models of tumour angiogenesis and anti-angiogenic strategies. IMA. J. Math. Appl. Med. Biol. 14 (1997) 189-205
24. Breward C.J.W., Byrne H.M., and Lewis C.E. A multiphase model describing vascular tumour growth. J. Math. Biol. 65 (2003) 609-640
25. Breward C.J.W., Byrne H.M., and Lewis C.E. Modelling the interaction between tumour cells and a blood vessel in micro-environment within a vascular tumour. Eur. J. Appl. Math. 12 (2001) 529-556
26. Hahnfield P., Panigraphy D., Folkman J., and Hlatky L. Tumour development under angiogenic signalling: A dynamic theory of tumour growth, treatment response and post-vascular dormancy. Cancer Res. 59 (1990) 4770-4775
27. d'Onfrio A., and Gandolfi A. Tumour eradication by anti-angiogenic therapy: Analysis and extension of the model by Hahnfeldt et al. (1999). Math. Biosci. 191 (2004) 154-184
28. Panovska J., Byrne H.M., and Maini P.K. Mathematical modelling of vascular tumour growth and implications for therapy. In: Deutsch A., Brusch L., Byrne H., de Vries G., and Herzel H.-P. (Eds). Mathematical Modeling of Biological Systems, Vol. I (2007), Birkhäuser, Boston 211-222
29. Griffiths L., and Daches G.U. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor thymidine phosphorylase in human breast tumour cells in vitro and in vivo. Cancer Res. 57 (1997) 570-572
30. De Angelis E., and Preziosi L. Advection-diffusion models for solid tumour evolution in vivo and related free boundary problems. Math. Models Methods Appl. Sci. 10 (2000) 379-407
31. Baxter L.T., Yuan F., and Jain R.K. Pharmacokinetic analysis of the perivascular distribution of bifunctional antibodies and haptens: Comparison with experimental data. Cancer Res. 525 (1992) 838-850
32. Sholley M.M., and Ferguson G.P. Mechanism of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. Lab. Invest. 51 (1984) 624-634
33. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., and Folkman J. Endostatin: An endogenous inhibitor of angiogenesis and tumour growth. Cell 88 (1997) 277-285
34. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., and Folkman J. Angiostatin. A novel angiogenic inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell 79 (1994) 315-328
35. West C.M., and Price P. Combretastatin A4 phosphate. Anticancer Drug. 15 3 (2004) 179-187
36. Ward J.P., and King J.R. Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures. Math. Biosci. 181 (2003) 177-207
37. Jackson T.L., and Byrne H.M. A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumours to chemotherapy. Math. Biosci. 164 (2000) 17-38
38. Arakelyn L., Merbi Y., and Agur Z. Vessel maturation effects on tumour growth: Validation of a computer model in implanted human ovarian carcinoma spheroids. Eur. J. Cancer 41 1 (2004) 159-167
39. Agur Z., Arakelyan L., Belilty G., Dahan N., Harpak H., Kogan Y., Merbl Y., Rabinovich A., Shoham M., and Ziv I. Application of the Virtual Cancer Patient Engine (VCPE) for improving oncological treatment design. J. Clin. Oncol. 22 14S (2004) 692-700
40. Sinek J., Frieboes H., Zheng X., and Cristini V. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumour response limitations involving nanoparticles. Biomed. Microdev. 6 4 (2004) 297-309
41. Zheng X., Wise S.M., and Cristini V. Non-linear simulator of tumour progression and interaction with the vasculature via an adaptive finite-element/level-set method. Bull. Math. Biol. 67 2 (2005) 211-259
42. Fister K.R., and Panetta J.C. Optimal control applied to cell-cycle-specific cancer chemotherapy. SIAM J. Appl. Math. 60 3 (2000) 1059-1072
43. Fister K.R., and Panetta J.C. Optimal control applied to competing chemotherapeutic cell-kill strategies. SIAM J. Appl. Math. 63 6 (2003) 1954-1971
44. Balding D., and McElwain D.L.S. A mathematical model of tumour-induced capillary growth. J. Theor. Biol. 114 (1985) 53-73
45. Edelstein L., and Segel L.A. Growth and metabolism in mycelial fungi. J. Theor. Biol. 104 (1983) 187-210
46. J. Panovska, Mathematical modelling of tumour growth and applications for therapy, D.Phil Thesis, Oxford University, UK, 2005
47. Stokes C.L., and Lauffenburger D.A. Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis. J. Theor. Biol. 152 (1991) 377-403
48. Press W.H., Teukolsky S.A., Vetterling W.T., and Flannery B.P. Numerical Recepies in Fortran: The Art of Scientific Computing. 2nd ed. (1994), Cambridge University Press
49. Degregorio M., Lui G., Macher B., and Wilbur J. Uptake, metabolism and cytotoxicity of doxorubicin in human ewing's carcinoma and rhabdomysarcoma cells. Cancer Chemo. Pharmacol. 12 (1984) 59-70
50. Jackson T.L. Intracellular accumulation and mechanism of action of doxorubicin in a spatio-temporal tumour model. J. Theor. Biol. 220 (2002) 210-213
51. Dordel M., Winter J.N., and Atkinson A.J. Kinetic analysis of P-glycoprotein-mediated doxorubicin effect. J. Pharmacol. Exp. Ther. 263 (1992) 762-780
52. Jackson T.L. Vascular tumour growth and treatment: Consequences of polyclonality, competition and dynamic vascular support. J. Math. Biol. 44 3 (2002) 201-226
53. Laderoute K.R., and Alarcon R.M. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and angiogenic inducer vascular endothelial growth factor. Clin. Cancer Res. 6 (2000) 2941-2950
54. http://www.hivandhepatitis.com/recent/virologic/011405_a.html
55. Pettet G.J., Please C.P., Tindall M.J., and McElwain D.L.S. The migration of cells in multicell tumour spheroids. Bull. Math. Biol. 63 (2001) 231-257